Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath

University Hospital Southampton NHS Foundation Trust.

Professor Gareth Thomas is Chair of Experimental Pathology at the University of Southampton. His laboratory focuses on the role of the tumour microenvironment in promoting tumour progression, investigating the interactions between different cell types. The work has a strong translational component, identifying potential prognostic/predictive biomarkers, therapeutic targets and molecular classifiers in cancer tissues, including the characterisation of cancer-associated fibroblasts and intratumoral immune cells, and development of immunotherapy clinical trials in squamous carcinoma of the head and neck.

dont miss

Targeted therapies: aiming at the tumour micro-environment

While immune checkpoint inhibitors such as -PD1, have shown efficacy across cancer types, most patients (~80%) fail to respond. Currently, it is unclear how to select patients most likely to benefit, or how to combine the expanding number of immunotherapies in development.

Our aim is to develop immune stratification for cancer patients; using NGS, bioinformatic analyses and in vivo modelling, we have characterised the molecular heterogeneity of tumour phenotypes; characterising prognostic/predictive lymphocyte signatures and identifying targetable immune evasion mechanisms. The seminar will discuss the potential for immune-based classification of cancers.

EVEN MORE SEMINARS

  • Professor David Maintz: Speaking at the Oncology Convention

    Professor David Maintz
    University Hospital Cologne, Department of Radiology

    Spectral CT: Dual layer technology helps to increase diagnostic confidence

  • Dr Anita Rose: Speaking at the Oncology Convention

    Dr Anita Rose
    The Raphael Hospital

    Cognitive Issues in Multiple Sclerosis

  • Cheng Boon: Speaking at the Oncology Convention

    Cheng Boon
    Worcestershire Royal Hospital

    Consultant Clinical Oncologist, GI and Head & Neck

  • Dr Tom Newsom-Davis: Speaking at the Oncology Convention

    Dr Tom Newsom-Davis
    Leaders in Oncology Care (Part of HCA healthcare UK)

    Immunotherapy and innovative systemic treatments in Oncology

  • Mylaine Riobe MD, FABOIM, FACOG: Speaking at the Oncology Convention

    Mylaine Riobe MD, FABOIM, FACOG
    Riobe Institute of Integrative Medicine

    Cancer is not random! Evolving mechanisms for cancer causation and prevention